Portman Holdings is looking at 111.55 acres in Duluth for a mixed-use project. The Atlanta Business Chronicle reports the plan is to build about 1,400 new residential units – including apartments, townhomes and single-family homes – along with approximately 80,000 square feet of commercial space and approximately 100,000 square feet of medical office space.

The site is nearly vacant, except for a historic house built in 1895. The Hudgens Company owns the parcel.

Construction on the large Duluth project could wrap up by 2031. The site last traded hands for $20.25 million in 2006, and its total appraised value across two parcels is $7.08 million.

Portman is also planning a mixed-use redevelopment of an Alpharetta office campus and a 332-unit apartment complex in Fairburn, among other projects.

The governing agency that runs the The University of Texas agreed on a spending measure that would allow the MD Anderson Cancer Center to move forward on a $2.9 billion expansion plan.

The school will bring in university revenue, financing bonds to supplement the hospital revenues that are also funding the project at the Texas Medical Center (photo) in Houston. In total, MD Anderson will commit around $1.6 billion from its hospital revenues for the project, while around $1.2 billion will come from the UT revenue bonds.

The funding will be used to build a new, standalone building to house the Therapeutic Radiation Center and a 25-floor patient care building. The 1.8 million square foot Therapeutic Radiation Center will include services focused on imaging and therapy, including infusion and cell therapies, diagnostic imaging, pathology and laboratory medicine, pharmacy, outpatient surgery, extended-stay beds, endoscopy, outpatient clinics and ancillary services.

The last phase of the project is set for final completion in October 2032.

Clarion Partners, LLC recently executed on more than a dozen highly curated single-asset healthcare investments totaling over $1 billion. Terms were not disclosed. The transactions expand New York City-based Clarion’s national healthcare footprint and deepen its relationships with established operators in key growth markets, along with underscoring its continued conviction in the healthcare real estate sector.

“We are pleased to have completed these acquisitions, reflecting our disciplined investment approach and deep sector expertise,” said Clarion president Josh Pristaw. “Healthcare real estate continues to present compelling opportunities, particularly in senior housing and post-acute care, where demographic trends and evolving patient needs are driving long-term demand.”

With the recent acquisitions, Clarion now owns 2,000 seniors housing units acquired through core, core-plus and value-add strategies; 133,000 square feet of newly delivered or recently renovated medical real estate; and a growing pipeline of ground-up seniors housing developments.

Rubicon Point Partners (RPP) and Canyon Partners has acquired the Shockwave Medical headquarters, a 201,078-square-foot, four-building R&D campus at 5353 Betsy Ross Dr. in Santa Clara, on behalf of Rubicon Point Fund II. Terms were not disclosed. The property is 100% NNN leased to Shockwave Medical, Inc., a medical device company and wholly owned subsidiary of Johnson & Johnson.

“This is the beginning of a billion-dollar investment strategy that we plan to deploy over the coming few years throughout the region,” said Ani Vartanian, co-founder and managing partner of RPP. “This acquisition represents the quality and caliber of assets we will continue to target: mission-critical real estate leased to world-class tenants in the most dynamic markets on the West Coast.”

The acquisition is the 10th joint venture between RPP and Canyon. CBRE National Office Partners served as the exclusive advisor to RPP.

Hear from LA Leadership on May 28.
Gain direct insight from Los Angeles leadership, including Mayor Karen Bass and former Mayor Antonio Villaraigosa, as they discuss policy, growth, affordable housing and the city’s future. Don’t miss this high-level conversation—secure your spot today: www.connectLA26.com

GM Development secured $130 million in project financing, enabling the company to begin redevelopment of a historic former Veterans Affairs (VA) hospital campus into a 493-unit Class A mixed-use community in Denver, Colorado.

The financing was arranged by Walker & Dunlop. Chris Rumul, Jason Silva, Cole Parker and Mike Valucci of Walker & Dunlop FHA Finance on behalf of GM Development. The project incorporates historic tax credits as a key component of the capital stack, enabling the adaptive reuse of the long-vacant property.

Located at the northwest corner of East 9th Avenue and Clermont Street, the 8.22-acre former VA hospital campus will be redeveloped into a Class A mixed-use community at 1055 North Clermont Street. The project will deliver 493 rental units. It will also include more than 50,000 square feet of retail and medical office space.

GM paid $41 million for the property in 2022.

L3 Campus and Aureon Partners have obtained a $53.7 million refinancing for the OnShore apartments, a 210-unit/636-bed student housing project near the campus of Embry-Riddle Aeronautical University in Daytona Beach.

A Walker & Dunlop Capital Markets Real Estate Finance led by Will Baker, Mike Shropshire, William Shell, and Doug McDaniel coordinated the 7-year, floating-rate loan with a four-year interest-only period provided by Freddie Mac. Austin Kinn at TSB Capital Advisors consulted on the transaction on behalf of the borrower.

OnShore is a Class A student housing community featuring two-and four-bedroom layouts. Amenities include an infinity pool, fitness center, study areas, a flight simulator, and an on-site shuttle to the nearby Embry-Riddle campus.

The property at 1100 Halifax Medical Center Dr. has maintained 98%+ occupancy since delivery in 2020.

BGO and its parent, Sun Life, made commercial real estate headlines last month with the announcement that multifamily owner/operator Bell Partners and BGO would combine businesses. Sizable as that transaction is, it’s far from the whole story BGO has to tell. In advance of his participation in Connect Los Angeles 2026 on May 28, for which he will be a member of the Industry Leaders panel, BGO managing partner, head of U.S. Jonathan Epstein discussed the investment thesis the firm is pursuing both domestically and globally.

Q: Has BGO’s investment outlook changed since the beginning of 2026, whether internationally or domestically? 

A: Our core thesis has not changed, but the path has been bumpier than we expected. Coming into the year, we held the view – against consensus – that a U.S. recession was not inevitable, that inflation was largely under control, and that capital markets were thawing. We still believe all of that. What’s shifted is the timeline. Mercurial trade policy, followed by geopolitical volatility, has delayed the recovery we were expecting rather than derailed it. 

Domestically, we remain constructive. We think the Fed has more room to cut, the 10-year is mostly anchored around 4% plus or minus 25 basis points, and U.S. growth is better than the headlines suggest—supported by outsized manufacturing capex, AI investment, productivity gains, and a policy backdrop that continues to incentivize onshoring. The numbers on that last point are striking: over a trillion dollars in announced U.S. manufacturing capital spending – roughly $270 billion in pharmaceuticals over the next 5-10 years, $200-300 billion in semiconductors, and $20-30 billion annually in defense and industrial. That’s a structural reindustrialization of the U.S. economy, and it creates durable real estate demand—for power, logistics, industrial, and the housing that supports those workforces. 

Internationally, the picture has actually improved. Europe is set up for what may be its strongest decade in two generations, with defense and capex spending, easing rates, and selective dislocation across the GP universe creating attractive entry points—particularly in Spain, Italy, the Nordics, Germany, and a re-priced UK. Asia Pacific is steadier, with Japan remaining a standout for office. 

At the firm level, we’ve also been building the platform with intention. In March, Sun Life—BGO’s parent — entered into an agreement to acquire Bell Partners, a leading U.S. multifamily investment and operating platform with approximately $10 billion of assets under management. Once closed, the transaction will bring BGO’s AUM above $100 billion and, combined with our existing exposure, take the platform to more than 40,000 owned units and over 70,000 total units under management. It reflects our strong conviction in U.S. multifamily – a sector where demand fundamentals remain durable, the country is structurally under-housed, and many global investors remain under-allocated. 

Q: How has BGO’s global cold-chain involvement evolved, and where are the regional supply dislocations? 

A: Cold storage has moved through distinct phases — from an overlooked niche a decade ago, to an institutional boom during COVID, to the recalibration we’ve been in since 2023. We think the next chapter is stabilization, and the setup is probably the most attractive it’s been since we entered the space. Supply has reset dramatically — deliveries are down roughly 65% from the 2023 peak — and permanent debt markets for stabilized core are back, which tells us institutional capital is committing again. In that environment, scale and discipline matter a lot more than they did during the boom. 

Our own footprint in the sector has deepened materially over the past five years. We started with a single real estate transaction in 2018, then participated in Lineage Logistics’ pre-IPO growth round—Lineage is now publicly traded. We’ve since launched a dedicated development vehicle for modern Class A facilities across the U.S., added smaller infill acquisitions, and engaged our lending and credit team in financing opportunities. That breadth — equity development, infill acquisitions, and credit — gives us multiple ways to deploy capital across the cycle. 

What stands out today is how uneven the supply picture looks across markets. Markets like Texas, parts of Florida, and Chicagoland have absorbed meaningful new supply above the long-term average, creating near-term disruption but eventual opportunity. In contrast, high-barrier markets like the Northeast and West Coast have seen limited new supply and remain more stable. We’re focused on markets where demand drivers — port volumes, food distribution networks, demographic growth — are strong but recent deliveries have been limited, and on tenant-driven development where underwriting is anchored to actual demand rather than speculation. Our pipeline today is weighted toward the Central and Western U.S., with meaningful allocations to the Southeast and Canada, and demand is almost entirely coming from food distribution, grocery, and pharma. 

On the demand side, we continue to see food manufacturers and pharmaceutical companies seeking supply chain control and bespoke facilities through new development. At the same time, we’re identifying value-add acquisition opportunities — potentially with tenants already in place —in markets experiencing near-term disruption, which we think could serve as attractive entry points. 

Q: Within the core plus universe, what sectors look especially attractive as we go through 2026? 

We organize our core plus strategy around three themes: Power & Logistics, Healthcare, and Housing. All three are being driven by durable demographic demand on one side and capital-markets dislocation on the other—which is what creates mid-risk, mid-return entry points. 

Power & Logistics is one of our largest allocations today and continues to deliver meaningful rent growth. The through-line is access to power—whether that’s modern logistics, advanced manufacturing, or industrial adjacent uses like cold storage and IOS. The constraint on new supply is real and getting tighter. 

Healthcare is where we have strong conviction on a forward basis. High-acuity medical office and pharma related cGMP have very durable demographic tailwinds, and portfolio aggregation dynamics in the sector are creating attractive entry points. Expect that allocation to grow meaningfully over the course of 2026. 

Housing rounds out the themes, and it may be where we have the deepest structural conviction of all. Delayed first-time homebuyer formation, a housing shortage of more than 4-5 million units, and a rent-versus-own affordability gap near a 25-year high are all durable demand drivers for institutional-quality multifamily – and values have yet to reconnect with prior cyclical highs, giving us the opportunity to acquire well-located assets at meaningful discounts to replacement cost. 

Across all three themes, we’re consistently underwriting to pricing below replacement cost and below intrinsic value, which we think is the most important discipline in this environment. 

Q: Where do you see the opportunities for BGO’s new U.S. value-add industrial strategy? 

A: We are one of the largest logistics investor/owners (Top 5) and a longstanding investor in the space in the US. We have been consistent investors in the space, up and down the risk spectrum and both equity and credit and currently we think this is one of the more favorable entry points for industrial we’ve seen in roughly two decades, and our various investment vehicle strategies are built to capture three distinct but reinforcing opportunities. 

The first is strategic acquisitions of high-quality logistics assets where temporary oversupply has pushed vacancy higher and created what we’d call “high-quality vacancy on sale.” We’re investing in top-quartile markets, at meaningful discounts to replacement cost, and creating value through mark-to-market leasing and lease-up. 

The second is selective development. New supply is down more than 50% from peak, and the development pipeline is approaching decade lows. That sets up a compelling window to build best-in-class product in markets we’ve identified through our data-science research models – but only where we have sufficient power. Grid bottlenecks have become the real gating factor for new development across most of the country, and that’s created a scarcity premium for sites that can actually be built. 

The third bucket is industrial-adjacent: powered land that can serve data center demand, infill IOS sites in constrained submarkets, and advanced-manufacturing assets benefiting from onshoring. These are adjacencies where our industrial platform gives us an edge on sourcing and underwriting, and they add diversification without diluting our core logistics thesis. 

Put simply, the macro tailwinds for industrial—above-trend growth, easing rates, automation, supply chain resilience, policy-driven reinvestment in U.S. manufacturing—are converging with a supply/demand imbalance squarely in our favor and normalizing capital markets. That combination doesn’t come along often.

Hear from LA Leadership on May 28.
Gain direct insight from Los Angeles leadership, including Mayor Karen Bass and former Mayor Antonio Villaraigosa, as they discuss policy, growth, affordable housing and the city’s future. Don’t miss this high-level conversation—secure your spot today: www.connectLA26.com 

Ascension Saint Thomas will break ground next month on its new full-service hospital and health campus in Clarksville. The health campus will be near the intersection of Highway 76 and Interstate 24.

The $148.5 million hospital will anchor a 96-acre integrated healthcare campus, bringing together physician partners, Tennessee Oncology, Tennessee Orthopaedic Alliance, Ascension Saint Thomas Heart, Howell Allen Clinic, along with a Montgomery County Emergency Medical Services station. The facility will open with 44 inpatient beds and provide emergency care, inpatient surgery, cardiology, women’s health, a NICU and additional services.

The campus will also include an inpatient rehabilitation hospital, outpatient surgery, advanced imaging and specialty ambulatory care, making it easier to deliver coordinated, high-quality care close to home at every stage of life.

Ascension Saint Thomas is working with Turner Construction and architect ESa.

Site work is wrapping up and construction workers are ready to start building on what will be a $3 billion development in Apex. The Triangle Business Journal reports RXR is developing the 1,200-acre Veridea site, which will start with two industrial buildings totaling 213,000 square feet. 1.3 million square feet of warehouse space is planned.

Summit House, the first apartment building, will go vertical in a few weeks with first delivery of units by the end of 2027 and completion in early 2028. Summit House will have 291 studio, one- and two-bedroom apartments in a four-story complex.

Other components of the venture include Veridea Crossing, the 220,000 square foot retail and office space within East Village. It will start opening in early 2028. That includes an anchor grocer opening in 2029. Construction on the Wake Tech’s new campus will start by the end of this year with a targeted opening in fall 2029 with 3,000 students.

Construction on the NC Children’s Hospital is expected to start in summer 2027, with the first phases delivering in 2031.